
Calian Group Ltd. (TSE:CGY – Free Report) – Analysts at Desjardins issued their Q1 2026 earnings estimates for Calian Group in a research note issued on Wednesday, November 26th. Desjardins analyst B. Poirier anticipates that the company will post earnings per share of $0.74 for the quarter. Desjardins has a “Buy” rating and a $66.00 price objective on the stock. The consensus estimate for Calian Group’s current full-year earnings is $4.95 per share. Desjardins also issued estimates for Calian Group’s Q2 2026 earnings at $0.89 EPS, Q3 2026 earnings at $0.86 EPS and Q4 2026 earnings at $1.10 EPS.
CGY has been the topic of a number of other research reports. Royal Bank Of Canada boosted their price target on Calian Group from C$58.00 to C$66.00 and gave the stock an “outperform” rating in a research report on Thursday. CIBC lifted their target price on Calian Group from C$59.00 to C$62.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Canaccord Genuity Group boosted their target price on Calian Group from C$60.00 to C$63.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Ventum Financial increased their price target on Calian Group from C$58.00 to C$62.00 and gave the company a “buy” rating in a research note on Thursday. Five research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of C$63.80.
Calian Group Stock Up 2.5%
Shares of CGY stock opened at C$54.11 on Monday. Calian Group has a 52-week low of C$37.70 and a 52-week high of C$54.35. The stock has a market cap of C$614.15 million, a price-to-earnings ratio of 30.74, a PEG ratio of 2.50 and a beta of 0.43. The firm’s 50-day moving average is C$50.48 and its 200-day moving average is C$48.82. The company has a debt-to-equity ratio of 39.54, a quick ratio of 1.20 and a current ratio of 1.29.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
See Also
- Five stocks we like better than Calian Group
- What is the Nikkei 225 index?
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- What is diluted earnings per share (Diluted EPS)?
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
